

Self-Regulation And Stem Cell Providers: Is A Favorable Shift In Culture Gaining Traction?
Recently, I taught a module on regulatory trends and RMAT strategy at a hands-on weekend clinical training event in Austin, one of those...


FDA, Patients, and Providers: A Brand New “Relation-shift.”
I’m very positive about the future role of the FDA in ensuring that stem cell and related therapies are safe and effective. And, because...
What About Treatment #2?
I am always challenged and intellectually stimulated when I feel as though I’ve identified a pattern, practice, or even consequence of...


An Ambassador In Your Corner… What you should know About My Upcoming Work In DC
Throughout the week of August 7th, I have visits in DC with top policymakers and regulators, politicians, stem cell industry leaders, resear


An FDA "RMAT" Clinical Trial Is Now In Reach To Stem Cell Therapy Providers: Here Are Five
In case you haven’t heard, last December, with the passage of the 21st Century Cures Act, Congress provided an avenue for FDA reform that...